Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-18 Tax Withholding |
2025-02-19 8:01 pm |
N/A N/A |
Genprex Inc. | GNPX | Berger Mark Stanley Chief Medical Officer |
585 | $0.41 | 22,471 (Direct) |
View |
2024-12-05 Option Award |
2024-12-06 5:48 pm |
N/A N/A |
Genprex Inc. | GNPX | Berger Mark Stanley Chief Medical Officer |
18,250 | $0 | 23,056 (Direct) |
View |
2024-02-18 Tax Withholding |
2024-02-21 4:34 pm |
N/A N/A |
Genprex Inc. | GNPX | Berger Mark Stanley Chief Medical Officer |
1,319 | $4.4 | 4,806 (Direct) |
View |
2023-02-18 Option Award |
2023-02-22 6:35 pm |
N/A N/A |
Genprex Inc. | GNPX | Berger Mark Stanley Chief Medical Officer |
245,000 | $0 | 245,000 (Direct) |
View |
2022-02-04 Option Award |
2022-02-08 4:32 pm |
2023-02-04 2032-02-04 |
Genprex Inc. | GNPX | Berger Mark Stanley Chief Medical Officer |
98,750 | $0 | 98,750 (Direct) |
View |
2021-09-27 Option Award |
2021-09-28 4:26 pm |
2022-09-27 2031-09-27 |
Genprex Inc. | GNPX | Berger Mark Stanley Chief Medical Officer |
550,000 | $0 | 550,000 (Direct) |
View |
2021-09-01 Option Award |
2021-09-03 5:04 pm |
N/A 2031-09-01 |
Actinium Pharmaceuticals Inc. | ATNM | Berger Mark Stanley Chief Medical Officer |
67,164 | $0 | 67,164 (Direct) |
View |
2020-08-12 Option Award |
2020-08-14 5:17 pm |
N/A 2030-08-12 |
Actinium Pharmaceuticals Inc. | ATNM | Berger Mark Stanley Chief Medical Officer |
46,667 | $0 | 46,667 (Direct) |
View |